SPY vs SUPN
SPDR S&P 500 ETF Trust (SPY) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
SPDR S&P 500 ETF Trust (SPY) common stock listed on US.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
SPY does not have a complete income-statement cache yet.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
SPY currently screens at market cap $0. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the SPY and SUPN stock pages for the full models.
Not investment advice.